SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Flowr Corporation says strategy in Portugal paying dividends

    By

    Flowr Corporation’s CEO has commented that the company’s strategy in Portugal is paying dividends after improvements to operational expertise. 

    Holigen Holdings Limited in Portugal is expecting to harvest at least 300kg of indoor-grown medical cannabis in the first quarter of 2022. The company is the wholly-owned subsidiary of Canada-based The Flowr Corporation.

    According to Flowr, Holigen is in the final stages of cultivating its strains BC Black Cherry and BC Strawnana, which have THC content levels above 29 per cent. The company expects to commence harvesting at its purpose-built indoor facility in Sintra, Portugal by the end of January 2022. 

    The Flowr Corporation CEO, Darryl Brooker, commented: “Our strategy in Portugal is appearing to pay dividends. We have worked very hard to improve the operational expertise at our indoor facility in Sintra and we are now seeing the results. 

    “The EU market is starved for premium medical cannabis and our team in Portugal, led by Tom Flow, is on the cusp of achieving a significant operational milestone for the company.

    “We are very much looking forward to the near-term results in Portugal and see the EU as an under-valued and under-appreciated part of our business.”

    The Flowr Corporation also announced it has completed its first shipment from Canada to Israel, consisting of premium cannabis across two strains for a total of (CAD)$825,000 (~£481,405), as part of a recent supply agreement.

    The shipment is the company’s first into the Israeli market and the first significant international export, with additional exports to Israel expected later this year.

    “We are extremely pleased to have completed our first shipment to Israel as part of our partnership with IMC and Focus Medical,” commented Brooker.

    “As the Israeli medical cannabis industry continues to grow, we expect the market to be an important destination for us to grow our brand and distribution reach internationally. 

    “As a result, we view this first shipment and this partnership as an important next step to becoming a significant international producer of cannabis with a globally recognised brand.”

    The shipment of cannabis was from Flowr’s K1 facility located in Kelowna, British Columbia.

    The second shipment to the Israeli market is expected in the first half of 2022.

    [activecampaign form=31]

    Stephanie Price

    Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine ‘Game Theory’ focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on “Medical Cannabis Explained”.